It has been demonstrated that Erythropoietin reduces myocardial ischemia-reperfusion injury, and the activation of PI3K/Akt signaling pathway and down-regulation of GSK-3β gene expression were required [29]. The gene discussed is AKT1; the disease is myocardial ischemia.